Compare Vir Biotechnology Inc. Common Stock (VIR) vs Direxion Daily FTSE China Bull 3x Shares (YINN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vir Biotechnology Inc. Common Stock vs Direxion Daily FTSE China Bull 3x Shares — how do they compare? Vir Biotechnology Inc. Common Stock trades at $10.54 (market cap $1.76B), while Direxion Daily FTSE China Bull 3x Shares trades at $24.46 (market cap $601.74M). The key difference: Vir Biotechnology Inc. Common Stock is far larger — about 2.9× Direxion Daily FTSE China Bull 3x Shares's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Direxion Daily FTSE China Bull 3x Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vir Biotechnology Inc. Common Stock for 0 Days and Direxion Daily FTSE China Bull 3x Shares for 26 Days on average.
| VIR | YINN | |
|---|---|---|
Market Cap | $1.76B | $601.74M |
Volume | 2,764,948 | 1,449,514 |
Sector | Health | Leveraged / Inverse |
52-Week High | $11.78 | $52.69 |
52-Week Low | $5.12 | $21.45 |
Typical Hold Time | 0 Days | 26 Days |
Enterprise Value | $1.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
YINN trades at $25.06, up 0.36% on the day, with technical indicators signaling a bearish trend from moving averages and neutral oscillators. Key financial ratios such as P/E, P/S, and ROE are unavailable in the provided data. A dividend of $0.56 is scheduled for payment on September 29, 2026. Recent news highlights China's economic policies and energy sector dynamics, which may indirectly influence the stock's performance.
The outlook for YINN is cautious due to bearish technical signals and lack of fundamental data. Risks include reliance on macroeconomic factors in China and potential regulatory changes. Investment opportunities hinge on future financial disclosures and positive developments in related sectors, but current indicators suggest limited upside without stronger earnings or valuation support.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →About Direxion Daily FTSE China Bull 3x Shares
YINN is a leveraged ETF that seeks daily investment results, before fees and expenses, of 300% (3x) of the daily performance of the FTSE China 50 Index. It is a tactical instrument designed for sophisticated traders seeking to magnify short-term bullish views on large-cap Chinese equities, primarily those trading on the Hong Kong Stock Exchange.
Read more on YINN →
